1. Kim, Hyungsoo, Kim, Heejung, Feng, Yongmei, Tocci, Stefania, Ronai, Ze'ev A. . PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity. In Science translational medicine, 12, . doi:10.1126/scitranslmed.aaz5683. https://pubmed.ncbi.nlm.nih.gov/32641491/
2. Downs, Isaac, Vijayan, Saptha, Sidiq, Tabasum, Kobayashi, Koichi S. 2016. CITA/NLRC5: A critical transcriptional regulator of MHC class I gene expression. In BioFactors (Oxford, England), 42, 349-57. doi:10.1002/biof.1285. https://pubmed.ncbi.nlm.nih.gov/27087581/
3. Zhong, Jinjin, Liu, Lulu, Lu, Yajie, Zhou, Wei, Su, Xin. 2022. NLRP3, NLRC4 and NLRC5 Gene Polymorphisms Associate with Susceptibility of Pulmonary Aspergillosis in Non-Neutropenic Patients. In Journal of clinical medicine, 11, . doi:10.3390/jcm11071870. https://pubmed.ncbi.nlm.nih.gov/35407478/
4. Liu, Zhaolin, Shen, Chenye, Li, Heng, Fei, Jian, Huang, Fang. 2023. NOD-like receptor NLRC5 promotes neuroinflammation and inhibits neuronal survival in Parkinson's disease models. In Journal of neuroinflammation, 20, 96. doi:10.1186/s12974-023-02755-4. https://pubmed.ncbi.nlm.nih.gov/37072793/
5. Brunschwiler, Fabienne, Nakka, Surender, Guerra, Jessica, Guarda, Greta. 2024. A Ménage à trois: NLRC5, immunity, and metabolism. In Frontiers in immunology, 15, 1426620. doi:10.3389/fimmu.2024.1426620. https://pubmed.ncbi.nlm.nih.gov/39035010/
智鼠故事 
